Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Psoriatic arthritis
When is it appropriate to restart TNF inhibitors in the setting of recurrent C. difficile infection and ongoing vancomycin taper?
What alternative treatments would you consider in a patient with psoriatic arthritis?
Related Questions
How do you assess the potential role of obesity in driving inflammatory joint symptoms?
Do you routinely screen for interstitial lung disease in patients with psoriatic arthritis?
How do you approach inflammatory arthralgias without synovitis in a patient with psoriasis?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
How do you manage active psoriatic arthritis in a patient with a history of HIV and anal squamous cell carcinoma (post-radiation one year ago), previously treated with apremilast and sulfasalazine but has ongoing disease?
When in the treatment of OA do you think it is optimal to offer LDRT?
Do you use naltrexone in your patients with fibromyalgia?
How do you decide when to use acid-suppressive medications for GI prophylaxis when patients are on prolonged corticosteroid therapy?
How often are you performing CT screening in CVID patients to screen for ILD?
How do you approach vaccination, particularly the use of live vaccines such as yellow fever, in a patient with rheumatoid arthritis receiving a TNF inhibitor who is planning travel to Africa?